A simple, rapid, and extractive spectrophotometric method was developed for the determination of some postsynaptic α-1 adrenoreceptor antagonists: doxazosin mesylate (DOX), terazosin (TRZ) and alfuzosine HCl (ALF) in pure forms and pharmaceutical formulations. The developed methods are based on the formation of yellow colored chloroform ion-pair complexes between the basic nitrogen of the drugs and dyes, namely: bromocresol green (BCG), bromothymol blue (BTB), methyl orange (MO) and alizarine red S (ARS), in acidic buffer of pH range 3.0-5.0. The formed complexes were extracted with chloroform or dichloromethane and measured at 418, 414, 425 and 426 nm for DOX, at 419, 415, 425 and 428 nm for TRZ and at 418, 412, 421 and 427 nm for ALF using BCG, BTB, MO and ARS, respectively. The analytical parameters and their effects on the reported systems are investigated. Beer's law was obeyed in the range 1.0-130 µg mL −1 with correlation coefficient (n = 6) ≥ 0.9991. The molar absorpitivity, Sandell sensitivity, detection and quantification limits were also calculated. The composition of the ion associates was found 1:1 by Job's method. The proposed methods have been applied successfully for the analysis of the studied drugs in pure forms and in pharmaceutical formulations with percentage recoveries ranging from 99.18-100.61. The results of the analysis were validated statistically. The results were in good agreement and compared with those obtained with reported methods.
High-performance liquid chromatography has been developed for the determination of DOX in biological fluid by fluorescence detector [2] [3] [4] , in which DOX in human plasma was extracted by liquid-liquid extraction. Solid-phase extraction was used to separate DOX from plasma samples and Zorbax CN column was used as stationary phase [5] . Spectrophotometric methods were used for determination of DOX in tablets by ion-pair and charge-transfer complexation reactions [6] .
Terazosin hydrochloride dihydrate (TRZ) is known chemically as 2-[4-(2-tetrahydrofuranyl)carbonyl]-1-piperazinyl-6,7-dimethoxy-4-quinazolinamine monohydrochloride dihydrate. TRZ is a highly selective potent α-1 adrenoreceptor antagonist. It is an effective drug for hypertension (high blood pressure) and benign prostatic hyperplasia (enlarged prostate). It causes the blood vessels (veins and arteries) to relax and ex-pand, improving blood flow. TRZ also relaxes muscles in the prostate and bladder neck, making it easier to urinate [7] .
Several analytical methods have been reported for the determination of TRZ in human plasma following intravenous or oral dosing. The methods described include high performance liquid chromatography (HPLC) with fluorescence detection [8] [9] [10] , mass spectrometric detection [11] and UV detection [12] , although such detector systems may not be available in most laboratories. X-ray fluorescence spectrometry is based on the formation of ion-pair associates with zinc-thiocyanate [13] . Electrochemical method uses potentiometric sensors and other voltammetric techniques [14, 15] . Terazosin has been determined by fluorimetry [16] and spectrophotometric methods [17] [18] [19] [20] [21] [22] .
Alfuzosin HCl (ALF), (R,S)-N-{3-[(4-amino-6,7--dimethoxy-2-quinazolinyl)methylamino]propyl} tetrahydro-2-furancarboxamide hydrochloride, is used in the treatment of benign prostatic hyperplasia (BPH). ALF is an α1-adrenoreceptor blocker, can cause smooth muscles in the bladder neck and prostate to relax, resulting in an improvement in urine flow and a reduction in symptoms of BPH [23] .
Literature survey revealed a selective, sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of ALF in human plasma [24] . A direct high-performance liquid chromatographic method is also reported for the determination of enantiomers of ALF in plasma [25, 26] . High-performance liquid chromatographic determination with fluorimetric detection is available for estimation of ALF in biological fluids [27] . ALF is estimated by HPLC with column switching [28] and by reverse phase performance liquid chromatography (RPHPLC) and high performance thin layer chromatography (HPTLC) [29] [30] [31] . Determination of ALF in pharmaceuticals, human serum and simulated gastric juice by voltammetry method is also found in literature [32] . ALF is determined by spectrophotometric and colorimetric methods in pharmaceutical preparations [33--37] . A Stability indicating spectrophotometric and spectrofluorimetric and HPTLC methods are also found for ALF in bulk as well as pharmaceutical formulations [38, 39] .
The studied drugs, DOX, TRZ and ALF, are selective antagonists of α1-adrenoreceptors and are quinazoline derivatives represented by the following structural formulas shown in Figure 1 .
Spectrophotometry is characterized by its speed and simplicity, accuracy and inexpensive instruments needed, and hence it is an important alternative to other analytical techniques with clear advantages in terms of cost of analysis. Extractive spectrophotometric procedures are popular for their sensitivity in the assay of drugs and, therefore, ion-pair extractive spectrophotometry has received considerable attention for the quantitative determination of many pharmaceutical compounds [40] [41] [42] [43] . In the present investigation, we report that the development of four accurate, reproducible, less time consuming and adequately sensitive extractive spectrophotometric methods based on the formation of ion-pair complexes between DOX, TRZ and ALF with anionic dyes, namely bromocresol green (BCG), bromothymol blue (BTB), methyl orange (MO) and alizarine red S (ARS) compared with other reported methods. The proposed methods were applied to the determination of DOX, TRZ and ALF in pure forms and in pharmaceutical formulations. These methods are validated by the statistical data.
EXPERIMENTAL Apparatus
All absorption spectra were made using a Unicam 930 (UV-Visible) spectrophotometer (Germany) with a scanning speed of 200 nm/min and a bandwidth of 2.0 nm and a Perkin-Elmer single beam spectrophotometer, equipped with 10 mm matched quartz cells. A Hanna pH-meter instrument (Portugal) (HI: 9321) was used for checking the pH of buffer solutions pH ranges from (2.0-7.0).
Materials and reagents
All chemicals and reagents were of analytical grade and water was always bidistilled water.
Materials
Pure samples -Doxazosin methylate (DOX) working standard, was supplied by EPICO, Egypt. Its purity was found to be 99.90%.
-Terazosin HCl (TRZ) working standard, was supplied by Abbott/Kahira, Egypt. Its purity was found to be 99.60%.
-Alfuzosin hydrochloride (ALF), working standard, was obtained from Sanofi, Amriya, Egypt). Its purity was found to be 99.80%.
Pharmaceutical preparations
The different pharmaceutical preparations were purchased from the commercial source in the local market.
1. Dosin tablets, 4.0 mg DOX per tab (EPICO, Egypt).
2. Duraci tablets, 4.0 mg DOX per tab (Bio-Ph, Egypt).
3. Itrin ® tablets, 5 mg TRZ per tab (Abbott/ /Kahira, Egypt).
4. Prostasin tablets, 5 mg TRZ per tab (Pharco, Egypt).
5. Xatral SR tablets, 5 mg ALF per tab (Sanofi, Amriya, Egypt).
Stock solutions
Stock standard solutions of DOX, TRZ and ALF (1.0 mg mL -1 ) were prepared by dissolving an exact weight (100 mg) of the studied drugs in 20 mL of bidistilled water, and further diluted to 100 mL with bidistilled water. Working test solutions (100 µg mL -1 ) of the studied drugs were prepared by dilution with bidistilled water. These solutions also were found to be stable for at least three days when kept in the refrigerator.
Reagents
Bromocresol green (BCG), bromothymnol blue (BTB), methyl orange (MO) and alizarine red S (ARS) were obtained from BDH Chemicals LTD, Poole, England, and used without further purification.
Stock solutions (1.0×10 −3 M) were prepared by dissolving the appropriate weight of BCG, BTB, MO and ARS in 10 mL methanol and diluting to 100 mL with bidistilled water. These solutions were stable for at least 1 week if kept in the refrigerator.
Series of buffer solutions of KCl-HCl (pH 1.5--4.2), NaOAc-HCl (pH 1.99-4.92), NaOAc-AcOH (pH 2.0-6.0) and potassium hydrogen phthalate-HCl (pH 2.0-7.0) were prepared by following the standard methods. The pH of each solution was adjusted to an appropriate value by addition of 0.2 M hydrochloric acid or sodium hydroxide with the help of a pH meter. Freshly prepared solutions were always employed [44] .
Construction of calibration curves DOX Aliquots of 0.1-5.0 mL of 100 µg mL -1 standard DOX solutions were transferred to 10 mL measuring flasks and 2.0 mL acetate buffers of pH 3.0 (using BCG and MO) or pH 2.5 (using BTB and ARS) were added, followed by addition of 0.5 mL of BCG (1.0×10 −3 M) or 1.0 mL of BTB, MO or ARS (1.0×10 −3 M) reagent solutions. The mixture was extracted with 5.0 mL chloroform by shaking for 2 min, and then allowed to stand for clear separation of the two phases and the chloroform layer was passed through anhydrous sodium sulphate and completed to 10 mL with chloroform in volumetric flask. The absorbance of the yellow colored complexes were measured at 418, 414, 425 and 426 nm using BCG, BTB, MO and ARS, respectively, against corresponding reagent blank similarly prepared without DOX. All measurements were made at room temperature (25±2 °C). The procedures were repeated for other analyte aliquots and calibration plots were drawn to calculate the amount of drug in unknown analyte samples.
TRZ
Aliquots of 0.1-1.4 mL of 100 µg mL -1 standard TRZ solutions (in case of BCG, BTB and MO) or aliquots of 0.1-2.6 mL of 500 µg mL -1 of standard TRZ solution (in case of ARS) were transferred to 10 mL measuring flasks, followed by addition of 2.0 mL acetate buffers of pH 3.5 (using BCG, MO or ARS) or pH 5.0 (using BTB), then 1.0 mL of BCG, BTB or MO (1.0×10 −3 M) or 2.5 mL of ARS (1.0×10 −3 M) reagent solutions. The mixture was extracted with 5.0 mL chloroform by shaking for 2.0 min, and then allowed to stand for clear separation of the two phases and the chloroform layer was passed through anhydrous sodium sulphate and completed to 10 mL with chloroform in volumetric flask. The absorbance of the yellow colored complexes were measured at 419, 415, 425 and 428 nm using BCG, BTB, MO and ARS, respectively, against corresponding reagent blank similarly prepared without TRZ. All measurements were made at room temperature (25±2 °C). The procedures were repeated for other analyte aliquots and calibration plots were drawn to calculate the amount of drug in unknown analyte samples.
ALF
Aliquots of 0.1-6.0 mL of 100 µg mL -1 standard ALF solutions were transferred to 10 mL measuring flasks, followed by addition of 2.0 mL acetate buffers of pH 2.5 (using BCG or BTB) or pH 3.0 (using MO or ARS), respectively, then 1.0 mL of BCG, BTB, MO or ARS (1.0×10 −3 M) reagent solutions. The mixture was extracted with 5.0 mL chloroform by shaking for 2.0 min, and then allowed to stand for clear separation of the two phases and the chloroform layer was passed through anhydrous sodium sulphate and completed to 10 mL with chloroform in volumetric flask. The absorbance of the yellow colored complexes were measured at 418, 412, 421 and 427 nm using BCG, BTB, MO and ARS, respectively, against corresponding reagent blank similarly prepared without ALF. All measurements were made at room temperature (25±2 °C). The procedures were repeated for other analyte aliquots and calibration plots were drawn to calculate the amount of drug in unknown analyte samples.
Procedures for pharmaceutical formulations (tablets)
The contents of twenty tablets: dosin tablets or duraci tablets, 4.0 mg DOX per tablet; itrin ® tablets or prostasin tablets, 5.0 mg TRZ per tablet; and xatral SR tablets, 5.0 mg ALF per tablet, were crushed, finely powdered, weighed out and the average weight of one tablet was determined for each drug. An accurate weight equivalent to 5.0 mg DOX, TRZ or ALF was transferred into a 50 mL calibrated flask, dissolved in 20 mL methanol with shaking for 5 min and filtered using Whatman No. 42 filter paper. The first 10 mL portion of the filtrate was rejected and the filtrate was diluted to 50 mL with bidistilled water in a 50 mL measuring flask to give 100 μg mL -1 stock solution. Aliquots of the cited solutions were taken and analyzed as described under the above recommended procedures for construction of calibration curves. For the proposed methods, the content of a tablet was calculated using the corresponding regression equation of the appropriate calibration graph.
Stoichiometric relationship
Job's method of continuous variation [45] of equimolar solutions was employed: a 5.0×10 -4 M standard solution of drugs base and 5.0×10 -4 M solutions of BCG, BTB, MO and ARS, respectively, were used. A series of solutions was prepared in which the total volume of the studied drugs and the dyes was kept at 5.0 mL. The drug and reagent were mixed in various complementary proportions (0:5, 1:4, 2:3, 5:0, inclusive) and completed as directed under the recommended procedures. The absorbance of the resultant ion-pair complex was measured at optimum wavelengths.
RESULTS AND DISCUSSION

Absorption spectra
The nitrogenous drugs are present in positively charged protonated forms and anionic dyes of sulphonphthalein group present mainly in anionic form at pH 2.5. So when treated with an acid dye at pH range (2.0-6.0) of acidic buffers solution, a yellow ion-pair complex which is extracted with chloroform is formed. The absorption spectra of the ion-pair complexes, which were formed between the studied drugs and each of BCG, BTB, MO and ARS were measured in the range 350-600 nm against the blank solution. The ion-pair complexes show maximum absorbance at 418, 414, 425 and 426 nm for DOX, 419, 415, 425 and 428 nm for TRZ and 418, 412, 421 and 427 nm for ALF using BCG, BTB, MO and ARS, respectively. Figure 2 presents the absorption spectra of the ionpair complexes, which formed between DOX and BCG and measured at 418 nm against the blank solution. The optimum reaction conditions for determination of the ion-pair complexes were established. Then, linearity, accuracy, precision, sensitivity and stability of proposed methods were described and these developed methods applied to pharmaceutical preparations and the obtained results evaluated statistically.
Optimum reaction conditions for complex formation
The optimization of the methods was carefully studied to achieve complete reaction formation, highest sensitivity and maximum absorbance. Reaction conditions of the ion-pair complex were found by studying with preliminary experiments such as pH of buffer, type of organic solvent, volumes of the dye, shaking time and temperature for the extraction of ion-pair complexes.
Effects of pH
The effect of pH on the drug-reagent complex was studied by extracting the colored complexes in the presence of various buffers such as KCl-HCl (pH 1.5-4.2), NaOAc-HCl (pH 1.99-4.92), NaOAc-AcOH (pH 2.0-6.0) and potassium hydrogen phthalate-HCl (pH 2.5-4.5). It was noticed that the maximum color intensity and highest absorbance value were observed in acetate buffer of pH 3.0 using BCG or MO and pH 2.5 using BTB or ARS, respectively for DOX, pH 3.5 using BCG, MO or ARS and pH 5.0 using BTB, respectively for TRZ, whereas, in case of ALF, pH 2.5 using BCG or BTB and pH 3.0 using MO or ARS, respectively (Figures 3-5) . In addition to the stability of the color without affecting the absorbance at the optimum pH values, 2.0 mL of the buffer solution gave maximum absorbances and reproducible results.
Effect of extracting solvents
The effect of several organic solvents viz., chloroform, carbon tetrachloride, methanol, ethanol, acetonitrile, n-butanol, benzene, acetone, ethyl acetate, diethylether, toluene, dichloromethane and chlorobenzene were studied for effective extraction of the colored species from aqueous phase. Chloroform was found to be the most suitable solvent for extraction of colored ion pair complexes for all reagents quantitatively. Experimental results indicated that double extraction with total volume 10 mL chloroform, yielding maximum absorbance intensity, stable absorbance for the studied drugs and considerably lower extraction ability for the reagent blank and the shortest time to reach the equilibrium between both phases.
Effects of reagent concentration
The effect of the reagents was studied by measuring the absorbances of solutions containing a fixed concentration of the studied drugs and varied amounts of the respective reagents. Maximum color intensity of the complex was achieved with 0.5 or 1.0 mL of 1.0×10 −3 M BCG or (BTB, MO and ARS), reagent solutions, respectively for DOX ( Figures 6-8 ); 1.0 or 2.5 ml of 1.0×10 −3 M (BCG, BTB and MO) or ARS reagent solutions, respectively for TRZ and 1.0 ml of 1.0×10 −3 M (BCG, BTB, MO and ARS) reagent solutions for ALF. A larger volume of the reagent had no pronounced effect on the absorbances of the formed ion-pair complex. 
Effect of time and temperature
The optimum reaction time was investigated from 0.5 to 5.0 min by following the color development at ambient temperature (25±2 °C). Complete color intensity was attained after 2.0 min of mixing for all complexes. The effect of temperature on colored complexes was investigated by measuring the absorbance values at different temperatures. It was found that the colored complexes were stable up to 30 °C. At higher temperatures, the drug concentration was found to increase due to the volatile nature of the chloroform. The stability of the ion-pair complexes was evaluated. The formation of the ion-pairs were rapid and the yellow color extracts were stable at least for least 6.0 h at room temperature for all drugdye reagents without any change in color intensity and the maximum absorbance at room temperature.
Stoichiometric relationship
In order to establish the molar ratio between the studied drugs and dyes, Job's method of continuous variation of equimolar solutions was applied. In all cases, the plot reached a maximum absorbance va- where DOX + and D − represent the protonated DOX and the anion of the dye, respectively, and the subcripts (aq) and (org) refer to the aqueous and organic phases, respectively.
Conditional stability constants (K f ) of the ion-pair complexes
The conditional stability constants (K f ) of the ionpair complexes for the studied drug were calculated from the continuous variation data using the following equation [46] :
where A is the observed maximum absorbance, A m is the absorbance value when all the drug present is associated, c M is the molar concentration of drug corresponding to maximum absorbance and n is the stoichiometry with which the dye ion associates with the drug. The log K f values for drug-dye ion-pair associates are presented in Table 1 .
Method validation procedures
The analytical method was validated according to the International Conference for Harmonization (ICH) guidelines [47] under the optimized experimental conditions: linearity, accuracy, precision, specificity and stability of ion pair complex.
Linearity
At the described experimental conditions for DOX, TRZ and ALF determination, calibration graphs for DOX, TRZ and ALF with BCG, BTB, MO and ARS, Table  1 . Sensitivity parameters such as apparent molar absorptivity and Sandell sensitivity of the resulting ion-pair complexes and relative standard deviation of response factors for each method are also summarized in Table 1 . The molar absorptivity of MO > BCG > BTB > ARS ion-pair complexes for DOX, BTB > BCG > MO > ARS ion-pair complexes for TRZ, while for ALF the molar absorptivity of BTB > BCG > MO > ARS ion-pair complexes. The statistical parameters were given in the regression equation calculated from the calibration graphs.
Sensitivity
The detection limit (LOD) for the proposed methods was calculated using the following equation [47] : LOD = 3.3s/k where s is the standard deviation of the response of the blank or the standard deviation of intercepts of regression lines and k is the sensitivity, namely the slope of the calibration curve. In accordance with the formula, the detection limits are presented in Table 1 .
The limit of quantitation, LOQ, was defined as [47] :
The calculated values are given in Table 1 .
Accuracy and precision
In order to evaluate the accuracy and precision of the proposed methods, solutions containing three different concentrations of each of the studied drugs were prepared and analyzed in six replicates. The analytical results of this investigation are summarized in Tables 2 and 3 . The low values of percentage relative standard deviation (% RSD) as precision and percentage relative error (% RE) as accuracy of the proposed methods were calculated. The percentage relative error was calculated using the following equation: % RE = ((found -added) / added)×100
The assay procedure was repeated six times, and percentage relative standard deviation (% RSD) values were obtained within the same day to evaluate repeatability (intra-day precision), and over five different days to evaluate intermediate precision (inter-day precision). These results of accuracy and precision show that the proposed methods have good repeatability and reproducibility.
Robustness and ruggedness
For the evaluation of the methods robustness, some parameters were interchanged: pH (±0.1), dye volume (±0.1 mL) and shaking time (±1.0 min). The capacity remained unaffected by small deliberate variations. Method ruggedness was expressed as % RSD (intermediate precision) of the same procedure applied by two analysts and in two different instruments on different days. The results showed no sta- Table 2 . Intra-day precision and accuracy data for DOX, TRZ and ALF obtained by the proposed methods 
Specificity and effects of interference
To assess the usefulness of the method, the effect of diluents, excipients and additives which often accompany DOX, TRZ and ALF in its dosage forms such as magnesium sterate lactose, microcrystalline cellulose, talc, glucose, dextrose and starch was studied. The good percentage recoveries were obtained indicating no interference was observed from any of these excipients and additives, indicating a high selectivity for determining the studied DOX, TRZ and ALF in its dosage forms.
Analysis of pharmaceutical preparations
The proposed methods have been successfully applied to the determination of DOX, TRZ and ALF in pharmaceutical dosage forms (tablets). Six replicate determinations were made. Moreover, to check the validity of the proposed methods, dosage forms were tested for possible interference with standard addition method (Table 4) . Therefore, it is concluded that the excipients in pharmaceutical dosage forms of DOX, TRZ and ALF were not found any interference in the analysis of DOX, TRZ and ALF. The results were compared with those obtained using a published methods. Statistical analysis of the results did not detect any significant difference between the performance of the proposed methods and reference methods or DOX [6] , TRZ [17] and ALF [33] in pharmaceutical formulations (Table 5) , with respect to accuracy and precision as revealed by the Student's t-value and variance ratio F-value at 95% confidence level [48] . The results show that the Student's t-and F-values at 95% confidence level are lower than the tabulated values.
Comparison of the methods
Comparing the results of the present proposed methods with the reference methods for DOX through ion-pair and charge-transfer complexation reactions [6] , spectrophotometric methods for TRZ [17] [18] [19] [20] [21] [22] and spectrophotometric and colorimetric methods for ALF [33] [34] [35] [36] [37] reveals that the present methods are simple and precise. The Beer's law limits were more extensive for the proposed methods and the ion-pair complexes were more stable and different buffer systems were used in proposed methods. Additionally, the LOD and LOQ values for proposed methods were lower than these methods in literature. 
CONCLUSION
In the present study, four simple, fast, extractive and cost effective spectrophotometric methods for the determination of some postsynaptic α-1 adrenoreceptor antagonist; doxazosin mesylate (DOX), terazosin (TRZ) and alfuzosine HCl (ALF) in pure forms and pharmaceutical formulations as tablets. The commonly used additives and excipients in pharmaceutical dosage forms of the studied drugs were not to interfere in the analysis. The reagents utilized in the proposed methods are cheaper, readily available, and the procedures do not involve any critical reaction conditions and tedious sample preparation. The pro-posed methods are simple and rapid. The maximum color development of ion-pair complex formation is completed immediately after all reagents were added. All the measurements were made in 30 min after the preparation of the solutions in all the experiments. No heating and standing was needed. Other methods in the literature, such as high performance liquid chromatography and gas chromatography methods, involve more procedural steps and take more operator time and expertise. However, the proposed spectrophotometric methods provide economic procedures, are less time consuming, and more sensitive and accurate compared with other reported methods of each drug. In this study precise and accurate results were validated by statistical analysis as per as the current ICH guidelines. The wide applicability of the new procedures for routine quality control is well established by the assay of the studied drugs in bulk forms, as well as in pharmaceutical preparations.
